Lastacaft FDA Approval History
Lastacaft (alcaftadine ophthalmic solution) is a topical H1 histamine receptor antagonist indicated for the prevention of itching associated with allergic conjunctivitis.
Development Timeline for Lastacaft
|Jul 28, 2010||ApprovalFDA Approves Lastacaft (alcaftadine ophthalmic solution) for Prevention of Itching Associated with Allergic Conjunctivitis|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.